Log In
BCIQ
Print this Print this
 

Cytotoxic T-lymphocyte associated protein 4 (CTLA4) (CD152)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Cytotoxic T-lymphocyte associated protein 4 (CTLA4) (CD152)

BCIQ
Print ChartPrint this
1 - Cancer 1 - Cancer 2 - Cancer 2 - Cancer 3 - Cancer 3 - Cancer
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIMarketed
Cancer

3

3

2

2

1

1




 Products Targeting Cytotoxic T-lymphocyte associated protein 4 (CTLA4) (CD152)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

16

$113.6M

$66.2M

$1,260.7M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today